# Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass

> **NCT00238342** · NA · UNKNOWN · sponsor: **Gynecologic Oncology Group** · enrollment: 2000 (estimated)

## Conditions studied

- Fallopian Tube Cancer
- Ovarian Cancer

## Interventions

- **GENETIC:** proteomic profiling
- **OTHER:** surface-enhanced laser desorption/ionization-time of flight mass spectrometry
- **PROCEDURE:** biopsy

## Key facts

- **NCT ID:** NCT00238342
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-10
- **Primary completion:** 2007-10
- **Final completion:** —
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2010-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00238342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00238342, "Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00238342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*